One of the joys of browsing secondhand shops is the possibility of finding old, perhaps restorable or hackable, electronics at low prices. Admittedly, they usually seem to be old flat-screen TVs, ...

Cardinal Health (CAH) closed at $210.93 in the latest trading session, marking a +1.25% move from the prior day. The stock outpaced the S&P 500's daily gain of 0.5%. At the same time, the Dow added ...

Cardinal Health (CAH) traded higher in the premarket on Tuesday after the pharmaceutical distributor increased its adjusted earnings outlook for fiscal 2026 to a level above the consensus ahead of its ...

Cardinal Health Inc.’s stock rose 5% Wednesday, after the drug distributor and medical products maker beat estimates for its fiscal fourth quarter and raised its guidance. Dublin, Ohio-based Cardinal ...

Barclays analyst Glen Santangelo initiated coverage of Cardinal Health, Inc. (NYSE:CAH) on December 9, giving the stock an Overweight rating and a $243 price target. The firm started its broader view ...

Analysts are saying that Cardinal Health could rise by 2030. Bullish on CAH? Invest in Cardinal Health on SoFi with no commissions. If it’s your first time signing up for SoFi, you’ll receive up to $1 ...

Please provide your email address to receive an email when new articles are posted on . Children with congenital adrenal hyperplasia have a shorter median height and higher body weight at age 20 years ...

Burmese pythons are an invasive species in South Florida, negatively impacting native wildlife and ecosystems. State and federal programs pay contracted hunters to find and remove the invasive snakes ...

Congenital adrenal hyperplasia (CAH) is a group of inherited conditions in which the adrenal glands cannot make certain hormones, most commonly due to a deficiency of the enzyme 21-hydroxylase. This ...

The treatments for both classic and nonclassic congenital adrenal hyperplasia (CAH) include medication, surgery, and psychological support, or a combination of all three. Some people who have CAH, ...

Cardinal Health (NYSE:CAH) announced on Tuesday that it has decided to spend roughly $1.9B in cash to acquire Solaris Health, a urology-focused healthcare management services organization (MSO).